Abstract
OBJECTIVE: To determine the prevalence of elevated C-reactive protein (CRP) in the Sandy Lake Oji-Cree, an aboriginal community residing in the Sioux Lookout zone of Northwestern Ontario, Canada, and to determine the associations of obesity and diabetes with CRP in a community with a very high prevalence of type II diabetes.
DESIGN: We surveyed 512 community members aged 18?y and older to determine the prevalence and the determinants of elevated CRP in Sandy Lake.
MEASUREMENTS:Clinical variables, indices of obesity and serum concentrations of CRP, insulin, serum amyloid A (SAA) and interleukin-6 (IL-6).
RESULTS: The prevalence of CRP ≥3.8?mg/l was significantly higher in women than in men (51% vs. 32%, P<0.0001). Regression analysis determined that body mass index and IL-6 were independent determinants of CRP concentration in women and waist circumference and IL-6 were independent determinants of CRP concentration in men. Diabetes was associated with elevated CRP in both sexes, but was only a moderate strong determinant in CRP concentration in multivariate regression analysis.
CONCLUSIONS: The prevalence of elevated CRP in this aboriginal community is remarkably high. These data further demonstrate that the association between CRP and specific indices of obesity and metabolism vary according to gender and glycemic status.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blake GJ, Ridker PM . High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis. Eur Heart J 2001; 22: 349–352.
Ridker PM, Hennekens CH, Buring JE, Rifai N . C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836–843.
Ridker PM . High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813–1818.
Rifai N, Ridker PM . Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem 2001; 47: 28–30.
Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB . C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237–242.
Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM . Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001; 47: 426–430.
Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E . Variability and classification accuracy of serial high-sensitivity C- reactive protein measurements in healthy adults. Clin Chem 2001; 47: 444–450.
Wener MH, Daum PR, McQuillan GM . The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 2000; 27: 2351–2359.
Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V . Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209–214.
Pickup JC, Mattock MB, Chusney GD, Burt D . NIDDM as a disease of the innate immune system: association of acute- phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286–1292.
Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972–978.
Lemieux I, Pascot A, Prud'homme D, Almeras N, Bogaty P, Nadeau A, Bergeron J, Despres JP . Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001; 21: 961–967.
Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner SM . Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42–47.
Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T . The association of C-reactive protein serum, amyloid A and fibrinogen with prevalent coronary heart disease. Atherosclerosis 2001; 156: 451–456.
Friso S, Jacques PF, Wilson PW, Rosenberg IH, Selhub J . Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation 2001; 103: 2788–2791.
Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM,, Gao J, Logan A, Zinman B . The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997; 20: 185–187.
Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Connelly PW, Zinman B . Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition. Diabetes Care 2001; 24: 1240–1247.
Shah BR, Hux JE, Zinman B . Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch Intern Med 2000; 160: 1862–1866.
Harris SB, Zinman B, Hanley A, Gittelsohn J, Hegele RA, Connelly PW, Shah B, Hux JE . The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diab Res Clin Prac 2002; 55: 165–173.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197.
Rifai N, Tracy RP, Ridker PM . Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999; 45: 2136–2141.
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB . Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199–204.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM . C-reactive protein, interleukin 6, and risk of developing type II diabetes mellitus. JAMA 2001; 286: 327–334.
Heilbronn LK, Noakes M, Clifton PM . Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001; 21: 968–970.
Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L, Witteman J, Graham I . Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease. and coronary artery disease. European COMAC Group. Circulation 1998; 97: 437–443.
Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, Hess DL, Davis CE . Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998; 98: 204–210.
Tanaka T, Robey FA . A new sensitive assay for the calcium-dependent binding of C-reactive protein to phosphorylcholine. J Immunol Methods 1983; 65: 333–341.
Carroll MC . The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998; 16: 545–568.
Circolo A, Garnier G, Fukuda W, Wang X, Hidvegi T, Szalai AJ, Briles DE, Volanakis JE, Wetsel RA, Colten HR . Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 1999; 42: 135–149.
Kildsgaard J, Hollmann TJ, Matthews KW, Bian K, Murad F, Wetsel RA . Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol 2000; 165: 5406–5409.
Albert MA, Danielson E, Rifai N, Ridker PM . Effect of statin therapy on C-reactive protein levels: The Pravastatin Inflammation/CRP Evaluation (PRINCE): A Randomized Trial and Cohort Study. JAMA 2001; 286: 64–70.
Van Lenten BJ, Wagner AC, Navab M, Fogelman AM . Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6. J Biol Chem 2001; 276: 1923–1929.
Cao H, Hegele RA . Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 2000; 45: 100–101.
Acknowledgements
The authors would like to acknowledge the following groups and individuals, whose cooperation was essential in the design and implementation of this project: the chief, council and community members of Sandy Lake First Nation; the Sandy Lake community surveyors (Louisa Kakegamic, Tina Noon, Madeliene Kakegamic, and Elda Anishinabie, Annette Rae, Connie Kakegamic, Mary Mamakeesic); the Sandy Lake nurses; the staff of the University of Toronto Sioux Lookout Programme; the Department of Clinical Epidemiology of the Samuel Lunenfeld Research Institute; Dr Alexander Logan, Annette Barnie and Sasan Mohammadi-Khah. This work was supported by grants from the National Institutes of Health (91-DK-01 and 1-R21-DK-44597-01), and the Ontario Ministry of Health (#04307) and the Canadian Diabetes Association.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Connelly, P., Hanley, A., Harris, S. et al. Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes 27, 347–354 (2003). https://doi.org/10.1038/sj.ijo.0802239
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802239
Keywords
This article is cited by
-
Potential Role of Undesirable Inflammatory Status in the Prediction of Metabolic Abnormalities Among Hypertensive Patients
SN Comprehensive Clinical Medicine (2019)
-
Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation
Journal of Endocrinological Investigation (2019)
-
Adiposity assessed by anthropometric measures has a similar or greater predictive ability than dual-energy X-ray absorptiometry measures for abdominal aortic calcification in community-dwelling older adults
The International Journal of Cardiovascular Imaging (2016)
-
Sex-related differences in the association between waist circumference and bone mineral density in a Korean population
BMC Musculoskeletal Disorders (2014)
-
Association of red blood cell n-3 polyunsaturated fatty acids with plasma inflammatory biomarkers among the Quebec Cree population
European Journal of Clinical Nutrition (2014)